StudyCanadaStudyCanada

← All news

McMaster researcher wins $50,000 ACE50 top prize to commercialize promising new antibiotic, plans spinout

Source publication : 2026-11-16 · McMaster University

Postdoctoral fellow Manoj Jangra won the Heersink ACE50 top prize of $50,000 on Nov. 16, 2026, for a pitch to commercialize lariocidins, a newly identified class of preclinical antibiotics from McMaster. The award will support formation of the planned Hamilton spinout Hammer Therapeutics and Jangra’s entry into a six-month Heersink ACE50 Fellowship to develop commercialization plans.

Manoj Jangra (Michael G. DeGroote Institute for Infectious Disease Research) secured the $50,000 Heersink ACE50 top prize on Nov. 16, 2026 for a pitch focused on advancing lariocidins — antibiotics discovered at McMaster. Funds are earmarked for company formation and branding for the planned spinout Hammer Therapeutics and to support hiring a postdoctoral or PhD trainee to de‑risk development. Jangra will join the six‑month Heersink ACE50 Fellowship for mentorship and commercialization coaching. Additional ACE50 faculty awards (several $25,000 and a $10,000 favourite prize) were also announced.

Read the original story · McMaster University — https://news.mcmaster.ca/pitch-to-commercialize-promising-antibiotic-earns-ace50-top-prize/

International students Current rules

The rules for studying in Canada.

Study permits, proof of funds, Québec requirements, work and options after graduation: explore the steps, amounts and tables in our complete guide.

Read the guide

Write to StudyCanada

Your plans or a question: let’s continue the conversation by email.

We will use these details to reply to your enquiry. Privacy